181 related articles for article (PubMed ID: 35768842)
21. GREM2 maintains stem cell-like phenotypes in gastric cancer cells by regulating the JNK signaling pathway.
Ran A; Guan L; Wang J; Wang Y
Cell Cycle; 2019 Oct; 18(19):2414-2431. PubMed ID: 31345097
[TBL] [Abstract][Full Text] [Related]
22. Spondin 2 promotes the proliferation, migration and invasion of gastric cancer cells.
Lu H; Feng Y; Hu Y; Guo Y; Liu Y; Mao Q; Xue W
J Cell Mol Med; 2020 Jan; 24(1):98-113. PubMed ID: 31691494
[TBL] [Abstract][Full Text] [Related]
23. Significance of SYT8 For the Detection, Prediction, and Treatment of Peritoneal Metastasis From Gastric Cancer.
Kanda M; Shimizu D; Tanaka H; Tanaka C; Kobayashi D; Hayashi M; Iwata N; Niwa Y; Yamada S; Fujii T; Sugimoto H; Murotani K; Fujiwara M; Kodera Y
Ann Surg; 2018 Mar; 267(3):495-503. PubMed ID: 28026832
[TBL] [Abstract][Full Text] [Related]
24. DLX6-AS1/miR-204-5p/OCT1 positive feedback loop promotes tumor progression and epithelial-mesenchymal transition in gastric cancer.
Liang Y; Zhang CD; Zhang C; Dai DQ
Gastric Cancer; 2020 Mar; 23(2):212-227. PubMed ID: 31463827
[TBL] [Abstract][Full Text] [Related]
25. Anthrax toxin receptor 1/tumor endothelial marker 8 promotes gastric cancer progression through activation of the PI3K/AKT/mTOR signaling pathway.
Cai C; Dang W; Liu S; Huang L; Li Y; Li G; Yan S; Jiang C; Song X; Hu Y; Gu J
Cancer Sci; 2020 Apr; 111(4):1132-1145. PubMed ID: 31977138
[TBL] [Abstract][Full Text] [Related]
26. LincHOTAIR epigenetically silences miR34a by binding to PRC2 to promote the epithelial-to-mesenchymal transition in human gastric cancer.
Liu YW; Sun M; Xia R; Zhang EB; Liu XH; Zhang ZH; Xu TP; De W; Liu BR; Wang ZX
Cell Death Dis; 2015 Jul; 6(7):e1802. PubMed ID: 26136075
[TBL] [Abstract][Full Text] [Related]
27. The calcium pump PMCA4 prevents epithelial-mesenchymal transition by inhibiting NFATc1-ZEB1 pathway in gastric cancer.
Wang T; Li N; Jin L; Qi X; Zhang C; Hua D
Biochim Biophys Acta Mol Cell Res; 2020 Dec; 1867(12):118833. PubMed ID: 32860837
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of MKK7-JNK by the TOR signaling pathway regulator-like protein contributes to resistance of HCC cells to TRAIL-induced apoptosis.
Song IS; Jun SY; Na HJ; Kim HT; Jung SY; Ha GH; Park YH; Long LZ; Yu DY; Kim JM; Kim JH; Ko JH; Kim CH; Kim NS
Gastroenterology; 2012 Nov; 143(5):1341-1351. PubMed ID: 22841785
[TBL] [Abstract][Full Text] [Related]
29. MTMR2 promotes invasion and metastasis of gastric cancer via inactivating IFNγ/STAT1 signaling.
Jiang L; Liu JY; Shi Y; Tang B; He T; Liu JJ; Fan JY; Wu B; Xu XH; Zhao YL; Qian F; Cui YH; Yu PW
J Exp Clin Cancer Res; 2019 May; 38(1):206. PubMed ID: 31113461
[TBL] [Abstract][Full Text] [Related]
30. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
[TBL] [Abstract][Full Text] [Related]
31. Amlodipine inhibits Synaptotagmin-4's oncogenic activity on gastric cancer proliferation by targeting calcium signaling.
Huang W; Yang S; Deng M; Luo R; Liang H; Shen Y; Yang B; Xu C; Hou Y
Funct Integr Genomics; 2024 Apr; 24(3):77. PubMed ID: 38632140
[TBL] [Abstract][Full Text] [Related]
32. WISP-2 in human gastric cancer and its potential metastatic suppressor role in gastric cancer cells mediated by JNK and PLC-γ pathways.
Ji J; Jia S; Jia Y; Ji K; Hargest R; Jiang WG
Br J Cancer; 2015 Sep; 113(6):921-33. PubMed ID: 26291058
[TBL] [Abstract][Full Text] [Related]
33. Exploring new frontiers: cell surface vimentin as an emerging marker for circulating tumor cells and a promising therapeutic target in advanced gastric Cancer.
Li H; Zhu YZ; Xu L; Han T; Luan J; Li X; Liu Y; Wang Z; Liu Q; Kong X; Zou C; Su L; Hou Y; Chen X; Chen L; Wang R; Xu Z; Zhao M
J Exp Clin Cancer Res; 2024 Apr; 43(1):129. PubMed ID: 38685125
[TBL] [Abstract][Full Text] [Related]
34. ERp29 controls invasion and metastasis of gastric carcinoma by inhibition of epithelial-mesenchymal transition via PI3K/Aktsignaling pathway.
Ye J; Huang J; Xu J; Huang Q; Wang J; Zhong W; Lin X; Li Y; Lin X
BMC Cancer; 2017 Sep; 17(1):626. PubMed ID: 28874138
[TBL] [Abstract][Full Text] [Related]
35. Neddylation controls basal MKK7 kinase activity in breast cancer cells.
Zhu T; Wang J; Pei Y; Wang Q; Wu Y; Qiu G; Zhang D; Lv M; Li W; Zhang J
Oncogene; 2016 May; 35(20):2624-33. PubMed ID: 26364603
[TBL] [Abstract][Full Text] [Related]
36. SUFU mediates EMT and Wnt/β-catenin signaling pathway activation promoted by miRNA-324-5p in human gastric cancer.
Peng Y; Zhang X; Lin H; Deng S; Qin Y; Yuan Y; Feng X; Wang J; Chen W; Hu F; Yan R; Zhao Y; Cheng Y; Wei Y; Fan X; Ashktorab H; Smoot D; Li S; Meltzer SJ; Jin Z
Cell Cycle; 2020 Oct; 19(20):2720-2733. PubMed ID: 33017570
[TBL] [Abstract][Full Text] [Related]
37. sMicroRNA-28-5p acts as a metastasis suppressor in gastric cancer by targeting Nrf2.
Yue CF; Li LS; Ai L; Deng JK; Guo YM
Exp Cell Res; 2021 May; 402(2):112553. PubMed ID: 33737068
[TBL] [Abstract][Full Text] [Related]
38. SYT7 acts as a driver of hepatic metastasis formation of gastric cancer cells.
Kanda M; Tanaka H; Shimizu D; Miwa T; Umeda S; Tanaka C; Kobayashi D; Hattori N; Suenaga M; Hayashi M; Iwata N; Yamada S; Fujiwara M; Kodera Y
Oncogene; 2018 Sep; 37(39):5355-5366. PubMed ID: 29858600
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-135b/CAMK2D Axis Contribute to Malignant Progression of Gastric Cancer through EMT Process Remodeling.
Huangfu L; He Q; Han J; Shi J; Li X; Cheng X; Guo T; Du H; Zhang W; Gao X; Luan F; Xing X; Ji J
Int J Biol Sci; 2021; 17(8):1940-1952. PubMed ID: 34131397
[TBL] [Abstract][Full Text] [Related]
40. Sensitization of Gastric Cancer Cells to 5-FU by MicroRNA-204 Through Targeting the TGFBR2-Mediated Epithelial to Mesenchymal Transition.
Li LQ; Pan D; Chen Q; Zhang SW; Xie DY; Zheng XL; Chen H
Cell Physiol Biochem; 2018; 47(4):1533-1545. PubMed ID: 29940566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
